Arthralgia as a side effect of methyldopa therapy
Peterson, S.H.
Journal of the American Osteopathic Association 76(5): 376
1977
ISSN/ISBN: 0098-6151 PMID: 584225 Document Number: 112189
Document emailed within 1 workday
Related Documents
Campbell, N.R.; Campbell, R.R.; Hasinoff, B.B. 1990: Ferrous sulfate reduces methyldopa absorption: methyldopa: iron complex formation as a likely mechanism Clinical and Investigative Medicine. Medecine Clinique et Experimentale 13(6): 329-332Borup Johansen, N.; Ayadipanah, M.; Sonnenschein, E.S.; Christensen, H.R.; Jürgens, G. 2013: Dizziness as a side effect of pharmacological therapy Ugeskrift for Laeger 175(45): 2720-2725
Fazekas, T.; Remák, G. 1985: Hyperthyroidism as a side effect of amiodarone therapy Orvosi Hetilap 126(38): 2339-2341
Rainova, R.; Kaloianov, K. 1974: Melanoderma as a side effect of cortisone depot therapy Vutreshni Bolesti 13(2): 120-122
Abuzarad, H.; Gadallah, M.F.; Rabb, H.; Vermess, M.; Ramirez, G. 1998: Emphysematous cystitis: possible side-effect of cyclophosphamide therapy Clinical Nephrology 50(6): 394-396
Liebetrau, G. 1984: Alveolitis--a rare side effect of gold therapy Zeitschrift für Erkrankungen der Atmungsorgane 163(2): 200-204
Karayianni, M.; von Heijne, A.; Laska, A-Charlotte. 2017: Encefalopathy as a side effect of metronidazole therapy – a case report Lakartidningen 114
Chaudhuri, M.D.; Bhan, G.L. 1984: Deep vein thrombosis: a side effect of steroid therapy British Journal of Clinical Practice 38(3): 118-119
Lu, Z.S.; Dong, X.T.; Zhang, T.J.; Cao, W.H.; Deng, Y. 1989: Relation between the therapeutic effect of moxibustion in treating arthralgia and SP and enkephalin in nervous tissues Journal of Traditional Chinese Medicine 9(1): 69-74
Nyfors, A. 1980: Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey Danish Medical Bulletin 27(2): 74-96
Koller, O.; Lehoczky, D. 1976: Immune hemolysis in the course of alpha methyldopa therapy Orvosi Hetilap 117(9): 545-546
Ajuriaguerra, J.; Gauthier, G.; Geissbuhler, F.; Simona, B.; Constantinidis, J.; Yanniotis, G.; Krassoievitch, M.; Eisenring, J.; Tissot, R. 1971: Substitution therapy of parkinsonism. Insufficient results with 3-0-methyldopa La Presse Medicale 79(30): 1396
Muenter, M.D.; Sharpless, N.S.; Tyce, G.M. 1972: Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease Mayo Clinic Proceedings 47(6): 389-395
Paik, N.J.; Han, T.R.; Im, M.S. 2001: Effect of facilitation on side-to-side H reflex amplitude ratio Electromyography and Clinical Neurophysiology 41(1): 3-7
Rabenalt, P. 1978: Monocytic neck lymphadenitis with morbileiform exanthema as side effect of penicillamine therapy of infantile Wilson's diseases Kinderarztliche Praxis 46(8): 436-439
Yahr, M.D.; Duvoisin, R.C.; Mendoza, M.R.; Schear, M.J.; Barrett, R.E. 1971: Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486) Transactions of the American Neurological Association 96: 55-58
Rosendorff, C. 1982: Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension South African Medical Journal 62(13): 435-437
Greene, J. 2002: Side by side. Communication is key to a successful side by side CEO-board chair partnership Trustee: the Journal for Hospital Governing Boards 55(5): 6
Ives, T.J.; Pevonka, M.P.; Andresen, B.D.; Yost, R.L. 1980: Effect of methyldopa on urine glucose test methods American Journal of Hospital Pharmacy 37(5): 683-687
Káldor, A.; Kállay, K.; Sebestyén, K.; Alexits, K. 1972: The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man Orvosi Hetilap 113(1): 23-24